Outcome of residual cholesteatoma and hearing in mastoid surgery
Roden, D.; Honrubia, V.F.; Wiet, R.
Journal of Otolaryngology 25(3): 178-181
1996
ISSN/ISBN: 0381-6605 PMID: 8783083 Document Number: 463812
Objective: To review 12 years of the senior author's experience with mastoid surgery for cholesteatoma. Design: Retrospective review. Setting: Northwestern University Medical School. Methods: Available records included 97 mastoid procedures for cholesteatoma: 54 with intact canal-wall and 43 canal-wall-down. Main Outcome Measures: Residual cholesteatoma, pure-tone audiometry, and speech audiometry were compared for both groups. Results: Residual disease rate was 11 of 54 (20%) for intact canal-wall procedures and 2 of 43 (5%) for canal-wall-down procedures. Average follow-up was 2 years. Hearing was preserved postoperatively, and neither procedure demonstrated clear superiority in this regard. Conclusion: While canal-wall-down mastoidectomy provides a lower residual disease rate with equal hearing outcome, the role of intact wall mastoidectomy remains a viable choice in certain clinical situations.